Tuberculosis Diagnostics Market is anticipated to reach USD 3.1 billion by 2024 owing to the introduction of enhanced diagnostic techniques like serological methods, IGRA (Interferon-gamma Release Assay), and nucleic acid testing. Tuberculosis is an infectious disorder caused by mycobacterium tuberculosis bacteria that attacks the lungs. The disorder can also spread to the other parts of the body like spine and brain. Depending on the type of tuberculosis suspected in the body, several tests are available for the diagnosis.
Request a Sample PDF Copy of This Report @ https://www.millioninsights.com/industry-reports/tuberculosis-diagnostics-market/request-sample
The key driving factors responsible for the growth of Tuberculosis
Diagnostics market :
Tuberculosis diagnostics industry
is influenced by factors like quick results and improved accuracy, increasing
government initiatives, growing elderly population and rising need for POC in
healthcare sector. However, tuberculosis diagnostics market is restrained by
significant cost of tuberculosis diagnosis and lack of awareness in patients.
Additionally, the increasing burden of tuberculosis is the major factor
expected to bring greater opportunities in tuberculosis diagnostics industry.
Tuberculosis diagnostics market
is categorized on the basis of test type, end user, and geography. On the basis
of test type, the market is divided into diagnostic laboratory methods,
detection of latent infection, nucleic acid testing, cytokine detection assay,
detection of drug resistance, radiographic method, and others. Diagnostic
laboratory segment is projected to hold larger market share of tuberculosis
diagnostics since it is easy to perform and cost effective.
Based on end user, tuberculosis
diagnostics industry is divided into clinics, research institutes &
academics, reference laboratories, hospitals, and others. Hospital segment is
predicted to register significant growth in the coming years owing to rising
preference for well-organized healthcare services by patients.
Geographically, tuberculosis
diagnostics market is segmented as North America, Latin America, Europe, Asia
Pacific and Middle East & Africa. North America is predicted to lead the
market of tuberculosis diagnostics owing to innovations in technology, approval
for novel medications and increasing incidences for TB in young people.
The prominent players in
tuberculosis diagnostics industry include Abbott, BioMrieux SA, Hain
Lifescience GmbH, Siemens, Cepheid, Thermo Fisher Scientific Inc., Becton,
Dickinson and Company, F. Hoffmann-La Roche AG, Hologic Corporation, and
Qiagen.
View Full Table of Contents of This Report @ https://www.millioninsights.com/industry-reports/tuberculosis-diagnostics-market
No comments:
Post a Comment